Targeted cancer therapy has been transforming the care of patients with non-small-cell lung cancer (NSCLC). It is now standard practice for tumor specimens from NSCLC patients to be examined for EGFR mutations and ALK rearrangements ...
Nov 15, 2012
It is common for patients initially diagnosed with lung cancer to have the cancer spread to sites like the liver, brain and bone. One of the most frequent sites of metastases is the bone, with an estimated 30 to 40 percent ...
Nov 15, 2012
Two studies published in the current issue of Cell Transplantation (21:7), now freely available on-line, investigate the role of oxygen in cell transplantation.
Nov 15, 2012
It's a popularly held belief that individuals with an autism spectrum disorder (ASD) gravitate toward STEM majors in college (science, technology, engineering mathematics).
Nov 15, 2012
Mesenchymal stem cells (MSCs), are a newly emerging cellular therapy being tested in approximately 250 clinical trials worldwide to help repair damaged tissues, such as injured heart muscle following a heart attack. The problem ...
Nov 15, 2012
Right now, the best known treatment for patients with metastatic non-small cell lung cancer (NSCLC) with anaplastic lymphoma kinase gene rearrangements (ALK) or epidermal growth factor receptor mutations (EGFR) is crizotinib ...
Nov 15, 2012
A study by researchers at the George Washington University School of Public Health and Health Services (SPHHS) indicates that full implementation of the Affordable Care Act would expand health insurance coverage for more ...
Nov 15, 2012
